URGN icon

UroGen Pharma
URGN

Overview Fund Activity

101 hedge funds and large institutions have $248M invested in UroGen Pharma in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 8 closing their positions.

Holders
101
Holders Change
+16
Holders Change %
+18.82%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
24
Increased
35
Reduced
22
Closed
8
Calls
$1.04M
Puts
$509K
Net Calls
+$533K
Net Calls Change
+$640K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$36.7M
2
RCM
2
RA Capital Management
Massachusetts
$20.8M
3
SCM
3
Silverarc Capital Management
Massachusetts
$7.13M
4
SCM
4
Soleus Capital Management
Connecticut
$5.21M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$2.91M

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$0
2
CI
2
Clal Insurance
Israel
$3.11M
3
OM
3
Opaleye Management
Massachusetts
$4.48M
4
MMH
4
Menora Mivtachim Holdings
Israel
$32.3M
5
Wells Fargo
5
Wells Fargo
California
$3.03M
Name Holding Trade Value Shares
Change 		Shares
Change %
Toronto Dominion Bank
101
Toronto Dominion Bank
Ontario, Canada
$84 +$84 +6 New
SCM
102
Stonepine Capital Management
Oregon
– -$4.64M -448,508 Closed
Cerity Partners
103
Cerity Partners
New York
– -$1.3M -125,226 Closed
EP
104
Eversept Partners
New York
– -$774K -74,797 Closed
XT
105
XTX Topco
Cayman Islands
– -$241K -23,323 Closed
State of Wisconsin Investment Board
106
State of Wisconsin Investment Board
Wisconsin
– -$157K -15,200 Closed
TI
107
Trexquant Investment
Connecticut
– -$153K -14,763 Closed
Squarepoint
108
Squarepoint
New York
– -$113K -10,920 Closed
CG
109
Cutler Group
California
– -$4K -400 Closed
1 2 3 4
5